BIP
ABBV icon

Bouvel Investment Partners’s AbbVie ABBV Stock Holding History

Bouvel Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.49M Buy
+37,712
New +$8.11M 2.15% 13

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Bouvel Investment Partners's ABBV Position: Q2 2026 in Review

Bouvel Investment Partners opened a new position in AbbVie (ABBV) in Q2 2026: 37,712 shares worth $9.49M. The stake represents 2.15% of the portfolio and ranks #13 among its holdings.

1,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bouvel Investment Partners held 37,712 shares of AbbVie worth $9.49M as of Q2 2026.
  • AbbVie was a new Bouvel Investment Partners position in Q2 2026.
  • AbbVie made up 2.15% of Bouvel Investment Partners's portfolio in Q2 2026, its #13 holding.
  • 1,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bouvel Investment Partners's 13F filing for Q2 2026, filed 17 Jul 2026.